← back to search

Paul Grogan

The University of Sydney · AU
Area of research
Oncology · Physiology
Research interest
Research interests include Global Cancer Incidence and Screening, Colorectal Cancer Screening and Detection, Smoking Behavior and Cessation, and COVID-19 and healthcare impacts.
h-index
18
citations
1,406
works
63
NIH funding
primary concept
email

Recent publications

Alcohol consumption, drinking patterns and cause-specific mortality in an Australian cohort of 181,607 participants aged 45 years and over
Public Health 2025cited by 7position: middledoi
The association between vaping and subsequent initiation of cigarette smoking in young Australians from age 12 to 17 years: a retrospective cohort analysis using cross-sectional recall data from 5114 adolescents
Australian and New Zealand Journal of Public Health 2024cited by 23position: middledoi
Pain and its interference with daily living in relation to cancer: a comparative population-based study of 16,053 cancer survivors and 106,345 people without cancer
BMC Cancer 2023cited by 34position: middledoi
A modelled evaluation of the impact of COVID-19 on breast, bowel, and cervical cancer screening programmes in Australia
eLife 2023cited by 22position: middledoi
Parent’s awareness of, and influence on, their 14–17-year-old child’s vaping and smoking behaviours; an analysis of 3242 parent–child pairs in Australia
Addictive Behaviors 2023cited by 15position: middledoi
Cancer incidence and mortality in Australia from 2020 to 2044 and an exploratory analysis of the potential effect of treatment delays during the COVID-19 pandemic: a statistical modelling study
The Lancet Public Health 2022cited by 94position: middledoi
Vaping product access and use among 14–17‐year‐olds in New South Wales: a cross‐sectional study
Australian and New Zealand Journal of Public Health 2022cited by 71position: middledoi
Cancer incidence and cancer death in relation to tobacco smoking in a population‐based Australian cohort study
International Journal of Cancer 2021cited by 65position: middledoi
How has COVID-19 impacted cancer screening? Adaptation of services and the future outlook in Australia
Public Health Research & Practice 2020cited by 155position: middledoi
Disability, psychological distress and quality of life in relation to cancer diagnosis and cancer type: population-based Australian study of 22,505 cancer survivors and 244,000 people without cancer
BMC Medicine 2020cited by 150position: middledoi
Alcohol consumption, drinking patterns and cancer incidence in an Australian cohort of 226,162 participants aged 45 years and over
British Journal of Cancer 2020cited by 48position: middledoi
Evaluating health benefits and cost-effectiveness of a mass-media campaign for improving participation in the National Bowel Cancer Screening Program in Australia
Public Health 2019cited by 48position: middledoi
Evaluation of the benefits, harms and cost‐effectiveness of potential alternatives to iFOBT testing for colorectal cancer screening in Australia
International Journal of Cancer 2018cited by 67position: middledoi
Benefits, Harms, and Cost-Effectiveness of Potential Age Extensions to the National Bowel Cancer Screening Program in Australia
Cancer Epidemiology Biomarkers & Prevention 2018cited by 55position: middledoi
Long-term evaluation of benefits, harms, and cost-effectiveness of the National Bowel Cancer Screening Program in Australia: a modelling study
The Lancet Public Health 2017cited by 164position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Karen Canfell · Sydney Local Health District11 papers (2017–2025)Sam Egger · University of Sydney6 papers (2020–2025)Emily Banks · Australian National University5 papers (2020–2025)Marianne Weber · The University of Sydney5 papers (2020–2025)Grace Joshy · Australian National University5 papers (2020–2025)Jie‐Bin Lew · The University of Sydney5 papers (2017–2023)Michael Caruana · University of Sydney4 papers (2017–2022)Emily He · The University of Sydney4 papers (2017–2023)Eleonora Feletto · The University of Sydney4 papers (2019–2023)Peter Sarich · The University of Sydney3 papers (2020–2025) · 3 papers (2017–2018) · 3 papers (2022–2024)Veerle M.H. Coupé · Novartis (Switzerland)3 papers (2017–2018) · 3 papers (2022–2024)Joachim Worthington · The University of Sydney2 papers (2019–2023)Carolyn Nickson · The University of Sydney2 papers (2020–2023)Mark A. Jenkins · Georgia Southern University2 papers (2018–2018) · 2 papers (2020–2023) · 2 papers (2017–2018) · 2 papers (2018–2018)